Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Pediatr ; 270: 114040, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-38554746

RESUMO

Infants with severe bronchopulmonary dysplasia may require high doses of neurosedative medications to ensure pain control and stability following tracheostomy placement. Subsequent weaning of these medications safely and rapidly is a challenge. We describe a 24-hour propofol infusion to reduce neurosedative medications in 3 high-risk infants following tracheostomy placement.


Assuntos
Displasia Broncopulmonar , Propofol , Traqueostomia , Humanos , Propofol/administração & dosagem , Traqueostomia/métodos , Masculino , Recém-Nascido , Feminino , Lactente , Hipnóticos e Sedativos/administração & dosagem , Infusões Intravenosas , Analgésicos/administração & dosagem , Analgésicos/uso terapêutico , Anestésicos Intravenosos/administração & dosagem , Dor Pós-Operatória/tratamento farmacológico
2.
Am J Physiol Endocrinol Metab ; 308(4): E306-14, 2015 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-25516551

RESUMO

Reduced fetal glucose supply, induced experimentally or as a result of placental insufficiency, produces an early activation of fetal glucose production. The mechanisms and substrates used to fuel this increased glucose production rate remain unknown. We hypothesized that in response to hypoglycemia, induced experimentally with maternal insulin infusion, the fetal liver would increase uptake of lactate and amino acids (AA), which would combine with hormonal signals to support hepatic glucose production. To test this hypothesis, metabolic studies were done in six late gestation fetal sheep to measure hepatic glucose and substrate flux before (basal) and after [days (d)1 and 4] the start of hypoglycemia. Maternal and fetal glucose concentrations decreased by 50% on d1 and d4 (P < 0.05). The liver transitioned from net glucose uptake (basal, 5.1 ± 1.5 µmol/min) to output by d4 (2.8 ± 1.4 µmol/min; P < 0.05 vs. basal). The [U-¹³C]glucose tracer molar percent excess ratio across the liver decreased over the same period (basal: 0.98 ± 0.01, vs. d4: 0.89 ± 0.01, P < 0.05). Total hepatic AA uptake, but not lactate or pyruvate uptake, increased by threefold on d1 (P < 0.05) and remained elevated throughout the study. This AA uptake was driven largely by decreased glutamate output and increased glycine uptake. Fetal plasma concentrations of insulin were 50% lower, while cortisol and glucagon concentrations increased 56 and 86% during hypoglycemia (P < 0.05 for basal vs. d4). Thus increased hepatic AA uptake, rather than pyruvate or lactate uptake, and decreased fetal plasma insulin and increased cortisol and glucagon concentrations occur simultaneously with increased fetal hepatic glucose output in response to fetal hypoglycemia.


Assuntos
Aminoácidos/metabolismo , Modelos Animais de Doenças , Doenças do Sistema Endócrino/embriologia , Gluconeogênese , Hipoglicemia/embriologia , Fígado/embriologia , Regulação para Cima , Algoritmos , Animais , Transporte Biológico , Glicemia/análise , Glicemia/metabolismo , Radioisótopos de Carbono , Doenças do Sistema Endócrino/sangue , Doenças do Sistema Endócrino/metabolismo , Feminino , Sangue Fetal , Glucagon/sangue , Ácido Glutâmico/sangue , Ácido Glutâmico/metabolismo , Glicina/sangue , Glicina/metabolismo , Hidrocortisona/sangue , Hipoglicemia/sangue , Hipoglicemia/metabolismo , Insulina/sangue , Fígado/metabolismo , Carneiro Doméstico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA